[Reduction of vital capacity by combined adjuvant chemotherapy (CMF) for breast cancer].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000494:pharmacology; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D008176:Lung Volume Measurements; D008727:Methotrexate / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D014797:Vital Capacity / Q000187:drug effects*
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate